Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of the fiscal period ended Monday, March 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
-0.28x
EV/EBIT RATIO AVG 3Y
-1.89x
EV/EBIT RATIO AVG 5Y
-7.82x
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$471.59M
EV/EBIT Ratio
N/A
TTM Avg
-15.91x
3Y Avg
-20.06x
5Y Avg
-20.06x
Market Cap
$2.64B
EV/EBIT Ratio
33.58x
TTM Avg
49.90x
3Y Avg
66.14x
5Y Avg
66.14x
Market Cap
$2.68B
EV/EBIT Ratio
22.29x
TTM Avg
19.45x
3Y Avg
19.45x
5Y Avg
21.26x
Market Cap
$6.19B
EV/EBIT Ratio
232.06x
TTM Avg
119.62x
3Y Avg
155.68x
5Y Avg
155.68x
Market Cap
$8.09B
EV/EBIT Ratio
558.28x
TTM Avg
400.88x
3Y Avg
145.86x
5Y Avg
145.86x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 23andMe Holding Co. (ME) | $15.31M | N/A | -0.28x | -1.89x | -7.82x |
| NRC Health (NRC)vs › | $439.69M | 35.02x | 18.94x | 18.09x | 19.56x |
| Shoulder Innovations, Inc. (SI)vs › | $471.59M | N/A | -15.91x | -20.06x | -20.06x |
| Teladoc Health, Inc. (TDOC)vs › | $1.21B | N/A | -3.74x | -5.94x | -19.44x |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 33.58x | 49.90x | 66.14x | 66.14x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.68B | 22.29x | 19.45x | 19.45x | 21.26x |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.19B | 232.06x | 119.62x | 155.68x | 155.68x |
| Tempus AI, Inc. (TEM)vs › | $7.69B | N/A | -27.13x | -28.45x | -29.28x |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | 558.28x | 400.88x | 145.86x | 145.86x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.80B | 40.27x | 38.89x | 33.09x | 33.09x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2025-03-31 | -0.20x |
| 2024-03-31 | -0.35x |
| 2023-03-31 | -2.25x |
| 2022-03-31 | -4.74x |
| 2021-03-31 | -21.30x |
| 2020-03-31 | -18.08x |
| 2019-03-31 | -19.31x |
